What is the share price of Global Health Ltd (MEDANTA) today?
The share price of MEDANTA as on 4th August 2026 is ₹1429.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Global Health Ltd (MEDANTA) share?
The past returns of Global Health Ltd (MEDANTA) share are- Past 1 week: 5.39%
- Past 1 month: 6.90%
- Past 3 months: 29.33%
- Past 6 months: 29.80%
- Past 1 year: 9.09%
- Past 3 years: 113.76%
- Past 5 years: 247.92%
What are the peers or stocks similar to Global Health Ltd (MEDANTA)?
The peers or stocks similar to Global Health Ltd (MEDANTA) include:What is the market cap of Global Health Ltd (MEDANTA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Global Health Ltd (MEDANTA) is ₹38814.17 Cr as of 4th August 2026.What is the 52 week high and low of Global Health Ltd (MEDANTA) share?
The 52-week high of Global Health Ltd (MEDANTA) is ₹1475.80 and the 52-week low is ₹956.What is the PE and PB ratio of Global Health Ltd (MEDANTA) stock?
The P/E (price-to-earnings) ratio of Global Health Ltd (MEDANTA) is 69.75. The P/B (price-to-book) ratio is 11.46.Which sector does Global Health Ltd (MEDANTA) belong to?
Global Health Ltd (MEDANTA) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Global Health Ltd (MEDANTA) shares?
You can directly buy Global Health Ltd (MEDANTA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Global Health Ltd
MEDANTA Share Price
NSE₹1,429.601.06% (-15.30)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MEDANTA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MEDANTA Performance & Key Metrics
MEDANTA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 69.79 | 11.46 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.01 | 6.02 | 0.49% |
89%
Analysts have suggested that investors can buy this stock
from 18 analysts
Price Upside
Earnings Growth
Rev. Growth
MEDANTA Company Profile
Global Health Limited, formerly Global Health Private Limited, is an India-based company. The Company is a tertiary care provider operating in the North and East regions of India. The Company operates approximately four hospitals under Medanta brand
APOLLOHOSP
PE Ratio
65.31
65.31
1Y Return
20.69%
20.69%
Buy Reco %
86.67
86.67
MAXHEALTH
PE Ratio
74.25
74.25
1Y Return
12.00%
12.00%
Buy Reco %
83.33
83.33
ASTERDM
PE Ratio
183.06
183.06
1Y Return
39.12%
39.12%
Buy Reco %
100.00
100.00
FORTIS
PE Ratio
68.12
68.12
1Y Return
9.06%
9.06%
Buy Reco %
85.00
85.00
PE Ratio
48.40
48.40
1Y Return
4.92%
4.92%
Buy Reco %
85.71
85.71
MEDANTA Sentiment Analysis
MEDANTA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
MEDANTA Stock Summary · November 2025
Medanta's recent operational developments reflect a strategic commitment to enhancing healthcare delivery while navigating the complexities of the market. The Noida hospital, which began operations in September 2025, has generated initial revenue but faces challenges in achieving immediate profitability due to ramp-up costs. Despite these hurdles, management remains optimistic about future growth, bolstered by a strong community response and plans for further expansion, including a new super specialty hospital in Guwahati. The company is also addressing insurance and payment challenges, particularly in the CGHS segment, while maintaining a robust financial position with a net cash surplus. Overall, Medanta's focus on clinical talent, advanced technologies, and operational efficiencies positions it well for sustainable growth in a competitive landscape.
MEDANTA Stock Growth Drivers
MEDANTA Stock Growth Drivers
7Expansion of Healthcare Facilities
The company has successfully commenced operations at its sixth hospital, Medanta Noida, which began in
Strong Financial Performance
In Q2 FY26, the company reported a consolidated total income of INR 11,189 million, reflecting
MEDANTA Stock Challenges
MEDANTA Stock Challenges
3Tapering Growth in Average Revenue Per Occupied Bed (ARPOB)
The growth in Average Revenue Per Occupied Bed (ARPOB) is currently tapering, with increases now
Challenges in CGHS Operations
Despite recent price increases in the Central Government Health Scheme (CGHS) business, the actual impact
MEDANTA Forecast
MEDANTA Forecasts
Price
Revenue
Earnings
MEDANTA Share Price Forecast
MEDANTA Share Price Forecast
2026
Current
₹1,444.90
Baseline
Forecast for Aug 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹1,444.90
Baseline
Forecast for Aug 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
MEDANTA Company Revenue Forecast
MEDANTA Company Revenue Forecast
2026
Current
₹4.51
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹4.51
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
MEDANTA Stock EPS (Earnings Per Share) Forecast
MEDANTA Stock EPS (Earnings Per Share) Forecast
2026
Current
₹20.71
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹20.71
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
MEDANTA
MEDANTA
Income
Balance Sheet
Cash Flow
Quarterly Normal View
MEDANTA Income Statement
MEDANTA Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 836.05 | 883.00 | 974.77 | 959.46 | 954.18 | 1,051.29 | 1,134.93 | 1,142.83 | 1,195.79 | 1,326.22 | ||||||||||
Operating & Other expenses | 629.28 | 674.76 | 728.27 | 705.67 | 756.46 | 784.26 | 868.28 | 940.35 | 915.28 | 1,017.30 | ||||||||||
EBITDA | 206.77 | 208.24 | 246.50 | 253.79 | 197.72 | 267.03 | 266.65 | 202.48 | 280.51 | 308.92 | ||||||||||
| Depreciation/Amortization | 45.45 | 46.62 | 49.43 | 48.45 | 49.25 | 45.11 | 49.73 | 61.19 | 66.52 | 68.98 | ||||||||||
| PBIT | 161.32 | 161.62 | 197.07 | 205.34 | 148.47 | 221.92 | 216.92 | 141.29 | 213.99 | 239.94 | ||||||||||
| Interest & Other Items | 18.23 | 17.98 | 15.98 | 16.28 | 15.03 | 13.79 | 17.11 | 21.51 | 26.71 | 26.68 | ||||||||||
| PBT | 143.09 | 143.64 | 181.09 | 189.06 | 133.44 | 208.13 | 199.81 | 119.78 | 187.28 | 213.26 | ||||||||||
| Taxes & Other Items | 15.71 | 37.37 | 50.25 | 46.16 | 32.04 | 49.13 | 41.37 | 24.76 | 43.29 | 54.54 | ||||||||||
| Net Income | 127.38 | 106.27 | 130.84 | 142.90 | 101.40 | 159.00 | 158.44 | 95.02 | 143.99 | 158.72 | ||||||||||
| EPS | 4.74 | 3.96 | 4.87 | 5.32 | 3.77 | 5.92 | 5.89 | 3.54 | 5.36 | 5.91 |
MEDANTA Company Updates
FY 2027FY 2027
Investor Presentation
Jul 30PDF
FY 2026FY 2026
Investor Presentation
May 14PDF
Feb 4PDF
Nov 7PDF
MEDANTA Stock Peers
MEDANTA Past Performance & Peer Comparison
MEDANTA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Global Health Ltd | 69.75 | 11.46 | — |
| Apollo Hospitals Enterprise Ltd | 65.31 | 11.43 | 0.23% |
| Max Healthcare Institute Ltd | 74.25 | 9.97 | 0.18% |
| Aster DM Quality Care Ltd | 183.06 | 19.46 | 0.21% |
MEDANTA Stock Price Comparison
Compare MEDANTA with any stock or ETFCompare MEDANTA with any stock or ETF
MEDANTA
MEDANTA Holdings
MEDANTA Shareholdings
MEDANTA Promoter Holdings Trend
MEDANTA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MEDANTA Institutional Holdings Trend
MEDANTA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
MEDANTA Shareholding Pattern
MEDANTA Shareholding Pattern
MEDANTA Shareholding History
MEDANTA Shareholding History
Foreign Institutions
Mutual Funds Invested in MEDANTA
Mutual Funds Invested in MEDANTA
No mutual funds holding trends are available
Top 5 Mutual Funds holding Global Health Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.0069% | Percentage of the fund’s portfolio invested in the stock 1.73% | Change in the portfolio weight of the stock over the last 3 months 0.27% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/71 (+8) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.5494% | Percentage of the fund’s portfolio invested in the stock 4.37% | Change in the portfolio weight of the stock over the last 3 months 0.45% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 6/50 (+4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.1302% | Percentage of the fund’s portfolio invested in the stock 1.97% | Change in the portfolio weight of the stock over the last 3 months 0.37% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 50/66 (+2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MEDANTA stock
smallcases containing MEDANTA stock
Looks like this stock is not in any smallcase yet.
MEDANTA Events
MEDANTA Events
MEDANTA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDANTA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MEDANTA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDANTA has not given any dividends in last 5 years
MEDANTA Upcoming Dividends
MEDANTA Upcoming Dividends
Cash Dividend
Ex DateEx DateAug 14, 2026
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Aug 14, 2026
MEDANTA Past Dividends
MEDANTA Past Dividends
Cash Dividend
Ex DateEx DateAug 22, 2025
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Aug 22, 2025
MEDANTA Stock News & Opinions
MEDANTA Stock News & Opinions
Articles & Videos
Corporate
Corporate
Global Health Limited reports Rs 13,262 million income, a 26.2% year-over-year riseGlobal Health Limited, which operates the Medanta hospital network (NSE: Medanta, BSE: 543654), announced its unaudited consolidated financial results for the quarter ending June 30, 2026, reporting total income of Rs 13,262 million, a 26.2% year-over-year increase. The company's EBITDA grew to Rs 3,153 million, up 23.5% year-over-year, while profit after tax was Rs 1,573 million. Global Health Limited added 72 new beds during the quarter, with 51 beds added in Noida and 21 in Lucknow, and plans to add 2,950 beds across five greenfield projects over the next few years.
4 days agoCapital Market - Live
Earnings
Earnings
Global Health consolidated net profit declines 0.18% in the June 2026 quarterNet profit of Global Health declined 0.18% to Rs 158.73 crore in the quarter ended June 2026 as against Rs 159.01 crore during the previous quarter ended June 2025. Sales rose 26.50% to Rs 1304.05 crore in the quarter ended June 2026 as against Rs 1030.84 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1304.051030.84 27 OPM %21.9923.92 - PBDT282.24253.25 11 PBT213.26208.14 2 NP158.73159.01 0 Powered by Capital Market - Live
4 days agoCapital Market - Live
Corporate
Corporate
Global Health Limited’s committee approved stock options for an employee under a 2024 schemeGlobal Health Limited announced that its Nomination and Remuneration Committee approved the grant of 20,000 stock options to one employee under Part-A of the Global Health Limited LTIP 2024 plan, a GHL Employees Stock Option Scheme, 2024, with an exercise price of Rs 1147 per share.
4 days agoCapital Market - Live
Corporate
Corporate
Global Health to convene board meetingGlobal Health will hold a meeting of the Board of Directors of the Company on 30 July 2026.
2 weeks agoCapital Market - Live
Spotlight
Spotlight
Volumes jump at Global Health Ltd counterBharat Electronics Ltd, Ashok Leyland Ltd, Physicswallah Ltd, Tata Chemicals Ltd are among the other stocks to see a surge in volumes on BSE today, 25 June 2026.Global Health Ltd saw volume of 10.02 lakh shares by 10:46 IST on BSE, a 60.42 fold spurt over two-week average daily volume of 16586 shares. The stock increased 0.52% to Rs.1,323.55. Volumes stood at 22858 shares in the last session.Bharat Electronics Ltd registered volume of 135.42 lakh shares by 10:46 IST on BSE, a 9.54 fold spurt over two-week average daily volume of 14.19 lakh shares. The stock slipped 0.68% to Rs.410.95. Volumes stood at 5.07 lakh shares in the last session.Ashok Leyland Ltd notched up volume of 148.9 lakh shares by 10:46 IST on BSE, a 8.28 fold spurt over two-week average daily volume of 17.97 lakh shares. The stock rose 2.52% to Rs.158.85. Volumes stood at 7.86 lakh shares in the last session.Physicswallah Ltd saw volume of 124.78 lakh shares by 10:46 IST on BSE, a 6.27 fold spurt over two-week average daily volume of 19.89 lakh shares. The stock increased 1.20% to Rs.126.60. Volumes stood at 5.26 lakh shares in the last session.Tata Chemicals Ltd clocked volume of 2.69 lakh shares by 10:46 IST on BSE, a 6.15 times surge over two-week average daily volume of 43789 shares. The stock gained 3.81% to Rs.755.30. Volumes stood at 18673 shares in the last session.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Global Health secures Govt. of Haryana's medical college projectGlobal Health has received a Letter of Intent (LOI) dated 11 June 2026 from the Medical Education & Research Department, Government of Haryana for establishment of a Medical College with 150 MBBS seats at Medanta - The Medicity, Sector-38, Gurugram, Haryana.
1 month agoCapital Market - Live
Earnings
Earnings
Global Health consolidated net profit rises 42.00% in the March 2026 quarterNet profit of Global Health rose 42.00% to Rs 143.99 crore in the quarter ended March 2026 as against Rs 101.40 crore during the previous quarter ended March 2025. Sales rose 24.46% to Rs 1159.05 crore in the quarter ended March 2026 as against Rs 931.25 crore during the previous quarter ended March 2025. For the full year,net profit rose 15.58% to Rs 556.46 crore in the year ended March 2026 as against Rs 481.44 crore during the previous year ended March 2025. Sales rose 19.44% to Rs 4410.27 crore in the year ended March 2026 as against Rs 3692.35 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1159.05931.25 24 4410.273692.35 19 OPM %21.0324.13 -20.8423.76 - PBDT253.80232.59 9 938.58890.91 5 PBT187.28183.34 2 716.04697.16 3 NP143.99101.40 42 556.46481.44 16 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Board of Global Health recommends Final DividendGlobal Health announced that the Board of Directors of the Company at its meeting held on 14 May 2026, has recommended a Final Dividend of Rs.0.50 per share (i.e.25%), subject to the approval of the shareholders.
2 months agoCapital Market - Live
Corporate
Corporate
Global Health to convene board meetingGlobal Health will hold a meeting of the Board of Directors of the Company on 14 May 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Global Health to hold board meetingGlobal Health will hold a meeting of the Board of Directors of the Company on 15 May 2026.
2 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 24.99%, vs industry avg of 16.34%
Over the last 5 years, market share increased from 3.51% to 4.9%
Over the last 5 years, net income has grown at a yearly rate of 80.78%, vs industry avg of 54.92%